Save to favorites
This feature is restricted to active members.
Join now to save favorites and get all member benefits, including over 1,400 product reviews.
Join NowAlready a member? Sign in here.
Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted March 12, 2026
Joint Juice $90 Million Class Action Settlement
Premier Nutrition Corporation has agreed to pay $90 million to settle a class action lawsuit alleging that its Joint Juice glucosamine products were falsely marketed to help improve joint health despite a lack of reliable scientific evidence. The lawsuit claimed that advertising and labeling led consumers to believe that regularly drinking Joint Juice could relieve joint pain and improve joint function.
(See ConsumerLab’s Joint Health Supplements Review, which discusses the clinical evidence for glucosamine for osteoarthritis and joint pain, as well as our Top Picks among joint health supplements.)
As part of the settlement, consumers in California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, New York, or Pennsylvania who purchased Joint Juice glucosamine products may be eligible to receive a cash payment. The deadline to submit a claim is May 18, 2026.
For more information, use the link below.
Joint Juice Settlement Website
See related recalls and warnings
Maker of Zicam Agrees to Pay $6 Million to Settle Lawsuit Over Claims to “Shorten Colds”
Report a Problem
If you have experienced an unexpected and adverse reaction to a dietary supplement, nutritional product, or generic drug, we would like to hear about it, as we may investigate the problem. Please select from one of these options:
Dietary Supplement or Nutritional Product Problem Report
Thank you for submitting your report to ConsumerLab. We have received your information, and it has been forwarded to our research team for review.
Due to the volume of reports we receive, we may not be able to respond individually. However, all submissions are carefully reviewed and may be investigated. We may publish information from this report, and/or it may help guide future testing or research.
